SG10201404895XA - Diagnosis - Google Patents

Diagnosis

Info

Publication number
SG10201404895XA
SG10201404895XA SG10201404895XA SG10201404895XA SG10201404895XA SG 10201404895X A SG10201404895X A SG 10201404895XA SG 10201404895X A SG10201404895X A SG 10201404895XA SG 10201404895X A SG10201404895X A SG 10201404895XA SG 10201404895X A SG10201404895X A SG 10201404895XA
Authority
SG
Singapore
Prior art keywords
diagnosis
Prior art date
Application number
SG10201404895XA
Inventor
Zeng Qi
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Priority to SG10201404895XA priority Critical patent/SG10201404895XA/en
Priority to EP15831971.5A priority patent/EP3189333A4/en
Priority to US15/503,155 priority patent/US20170234880A1/en
Priority to CN201580052886.7A priority patent/CN106716132A/en
Priority to JP2017507713A priority patent/JP2017526916A/en
Priority to SG11201701076TA priority patent/SG11201701076TA/en
Priority to PCT/SG2015/050259 priority patent/WO2016024918A1/en
Publication of SG10201404895XA publication Critical patent/SG10201404895XA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
SG10201404895XA 2014-08-13 2014-08-13 Diagnosis SG10201404895XA (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SG10201404895XA SG10201404895XA (en) 2014-08-13 2014-08-13 Diagnosis
EP15831971.5A EP3189333A4 (en) 2014-08-13 2015-08-13 Diagnosis of cancer
US15/503,155 US20170234880A1 (en) 2014-08-13 2015-08-13 Diagnosis of cancer
CN201580052886.7A CN106716132A (en) 2014-08-13 2015-08-13 Diagnosis of cancer
JP2017507713A JP2017526916A (en) 2014-08-13 2015-08-13 Diagnosis of cancer
SG11201701076TA SG11201701076TA (en) 2014-08-13 2015-08-13 Diagnosis of cancer
PCT/SG2015/050259 WO2016024918A1 (en) 2014-08-13 2015-08-13 Diagnosis of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201404895XA SG10201404895XA (en) 2014-08-13 2014-08-13 Diagnosis

Publications (1)

Publication Number Publication Date
SG10201404895XA true SG10201404895XA (en) 2016-03-30

Family

ID=55304429

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201404895XA SG10201404895XA (en) 2014-08-13 2014-08-13 Diagnosis
SG11201701076TA SG11201701076TA (en) 2014-08-13 2015-08-13 Diagnosis of cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201701076TA SG11201701076TA (en) 2014-08-13 2015-08-13 Diagnosis of cancer

Country Status (6)

Country Link
US (1) US20170234880A1 (en)
EP (1) EP3189333A4 (en)
JP (1) JP2017526916A (en)
CN (1) CN106716132A (en)
SG (2) SG10201404895XA (en)
WO (1) WO2016024918A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018075825A1 (en) * 2016-10-19 2018-04-26 Northwestern University Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer
CN107058556A (en) * 2017-05-09 2017-08-18 大连海事大学 It is a kind of to be used to assess the method that 5a,6,9,9a-hexahydro-6,9-methano-2,4 promotees cancer risk
CN110684770B (en) * 2017-12-11 2021-01-12 浙江大学 Application of hsa-miR-10434 miRNA sequence in tumor resistance
CN110531082A (en) * 2018-05-25 2019-12-03 国家纳米科学中心 For breast cancer detection and the excretion body detection device and application of molecule parting
EP4194856A1 (en) * 2020-08-06 2023-06-14 LSI Medience Corporation Diagnosis method for bladder cancer
CN112698033A (en) * 2020-12-09 2021-04-23 复旦大学附属中山医院 Detection method and application of blood-borne exosome HER2

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1848742A1 (en) * 2005-01-28 2007-10-31 Attogen, Inc. Anti-prl-3 antibodies and methods of use thereof
GB2462048B (en) * 2007-05-03 2012-03-21 Agency Science Tech & Res Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
EP2350320A4 (en) * 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings Methods and systems of using exosomes for determining phenotypes
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
US10258676B2 (en) * 2011-09-06 2019-04-16 Agency For Science, Technology And Research Polypeptide vaccine

Also Published As

Publication number Publication date
CN106716132A (en) 2017-05-24
EP3189333A4 (en) 2018-04-18
WO2016024918A1 (en) 2016-02-18
EP3189333A1 (en) 2017-07-12
JP2017526916A (en) 2017-09-14
US20170234880A1 (en) 2017-08-17
SG11201701076TA (en) 2017-03-30

Similar Documents

Publication Publication Date Title
AU361515S (en) Dishrack
AU362944S (en) Lapboard
PT3094237T (en) Electrocardiograph
IL250017A0 (en) Ophthalmoscopes
DK3178931T3 (en) Anti-orai1-antistof
SG10201404895XA (en) Diagnosis
PL3190964T3 (en) Spirometer
DK3002465T3 (en) Hydrauliksystem
GB201409851D0 (en) Diagnostic method
GB201504297D0 (en) Diagnosis
GB201408875D0 (en) Diagnostic method
GB201406616D0 (en) Imaging
DK3145380T3 (en) Toiletventilationssystem
GB201414421D0 (en) Techflush unit
GB201516557D0 (en) Diagnosis
AU5594P (en) Lanoregon Mandevilla sanderi
AU5598P (en) Lanidaho Mandevilla sanderi
AU5593P (en) Lanmissouri Mandevilla sanderi
AU5585P (en) Lanutah Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi
AU5584P (en) Laniowa Mandevilla sanderi
AU5583P (en) Lanminnesota Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5287P (en) FLOMANPIW Mandevilla sanderi